Vaginal Progesterone as a Treatment for Women Active Preterm Labor

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Labor, Premature
Interventions
DRUG

Vaginal progesterone gel

Subjects will receive daily vaginal progesterone gel provided by Columbia laboratories (1.125g progesterone gel containing 90mg (8%) progesterone)

DRUG

Placebo vaginal gel

Subjects will receive daily placebo vaginal gel, made of an identical bioadhesive delivery system as the active drug

Trial Locations (1)

14642

Strong Memorial Hospital, Rochester

Sponsors
All Listed Sponsors
collaborator

Juniper Pharmaceuticals, Inc.

INDUSTRY

lead

University of Rochester

OTHER